These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2146459)

  • 21. A 35-year-old pregnant woman considering maternal serum screening and amniocentesis.
    Mennuti M
    JAMA; 1996 May; 275(18):1440-6. PubMed ID: 8618372
    [No Abstract]   [Full Text] [Related]  

  • 22. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
    DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
    N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antenatal diagnosis of Down's syndrome].
    Liu ZJ; Liang DY; Chen M
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):732-4. PubMed ID: 21176551
    [No Abstract]   [Full Text] [Related]  

  • 25. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective birth in a dyzygotic twin pregnancy with discordancy for Down's syndrome.
    Pijpers L; Jahoda MG; Reuss A; Sachs ES; Los FJ; Wladimiroff JW
    Fetal Ther; 1989; 4(1):58-60. PubMed ID: 2535009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chorionic villus sampling and amniocentesis for prenatal diagnosis.
    Stranc LC; Evans JA; Hamerton JL
    Lancet; 1997 Mar; 349(9053):711-4. PubMed ID: 9078211
    [No Abstract]   [Full Text] [Related]  

  • 28. Gradual implementation of first trimester screening in a population with a prior screening strategy: population based cohort study.
    Calda P; Sípek A; Gregor V
    Acta Obstet Gynecol Scand; 2010 Aug; 89(8):1029-33. PubMed ID: 20524903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal diagnosis: chances, choices.
    Roberts SF
    J Fla Med Assoc; 1997; 84(6):374-8. PubMed ID: 9379162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antenatal screening for Down's syndrome with the quadruple test.
    Wald NJ; Huttly WJ; Hackshaw AK
    Lancet; 2003 Mar; 361(9360):835-6. PubMed ID: 12642052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group.
    Piggott M; Wilkinson P; Bennett J
    J Med Screen; 1994 Jan; 1(1):45-9. PubMed ID: 8790485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amniocentesis and informed consent.
    Drummond M; Knight L
    Br Med J (Clin Res Ed); 1988 Feb; 296(6621):566-7. PubMed ID: 11659101
    [No Abstract]   [Full Text] [Related]  

  • 34. Second-trimester amniocentesis vs. chorionic villus sampling for prenatal diagnosis in multiple gestations.
    Antsaklis A; Souka AP; Daskalakis G; Kavalakis Y; Michalas S
    Ultrasound Obstet Gynecol; 2002 Nov; 20(5):476-81. PubMed ID: 12423485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities.
    Rhoads GG; Jackson LG; Schlesselman SE; de la Cruz FF; Desnick RJ; Golbus MS; Ledbetter DH; Lubs HA; Mahoney MJ; Pergament E
    N Engl J Med; 1989 Mar; 320(10):609-17. PubMed ID: 2645520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
    Wald NJ; Watt HC; Hackshaw AK
    N Engl J Med; 1999 Aug; 341(7):461-7. PubMed ID: 10441601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Economic analysis of the dissemination of a medical innovation: prenatal diagnosis by early amniocentesis as an example. Part 2. Facilitating decision making in public health for optimal dissemination of an innovation].
    Gardent H; Fardeau M; Lanöe JL; Kerleau M
    Rev Epidemiol Sante Publique; 1984; 32(2):97-106. PubMed ID: 6237394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rapid prenatal diagnosis of Down's syndrome in the first trimester of pregnancy by fluorescence in situ hybridization].
    Xiang Y; Sun N; Wang F
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):646-8. PubMed ID: 9639761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down's syndrome: current screening techniques.
    White RS
    South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.